Jim Schwier

About

Jim leads all day to day operations for Nanocopoeia’s business, technology and portfolio development. Jim brings more than 30 years of global Brand and generic pharmaceutical manufacturing, product commercialization, engineering and operational excellence expertise. Prior to joining Nanocopoeia as Chief Operating Officer, Jim successfully led multiple operational/ business turn-arounds in both Brand and generic businesses serving in senior and executive leadership roles for companies such as; Teva Pharmaceuticals, Actavis/Watson, Perrigo, Paddock Labs, Par Pharmaceuticals, Andrx Pharmaceuticals, Pfizer and Parke-Davis(Warner-Lambert).

Investment Focus

Location

US